| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
GeeYee Inc. is a North Chicago, IL-based company in the Software and Internet sector.
Revitas is the industry leader in integrating contract, revenue, and compliance management for improved business outcomes. Revitas products deliver integrated solutions for contracts, pricing, and compliance that drive higher profitability and lower risk. Revitas empowers companies to optimize contract performance by defining, managing, and analyzing complex, multi-tier pricing incentives and enabling positive proof of compliance with commercial, financial, and industry requirements. Powered by the secure, scalable, and standards-based Flex platform, Revitas applications speed time to market and improve visibility across B2B relationships. Hundreds of organizations across the most highly regulated and challenging industries leverage Revitas’s integrated solutions to save money, make money, and reduce risk.
Zen Images Inc. is a Montreal, QC-based company in the Software and Internet sector.